About PrEP

What is PrEP?

A medicine that has been used to treat people who have HIV, can also be given to HIV-negative people to prevent an infection with HIV before someone is actually exposed. This is called preexposure prophylaxis of HIV or PrEP.

The drug that is currently being used for PrEP is called TRUVADA, and it is made by Gilead Sciences, Inc.

As a treatment for people who already have HIV, TRUVADA is approved for use in Australia, the United States, and other countries. As a medicine for PrEP, to lower chances of HIV in those who are not infected, TRUVADA has been approved in the US, but not in Australia yet.

There are a number of resources online available to learn more about PrEP:

Chevron Learn more about the PRELUDE study
Chevron Learn more about accessing PrEP outside the PRELUDE study here (external link)

One response to About PrEP

  1. Fully PrEPPed : Star Observer

    […] It is not licensed here for use as PrEP. However, a number of trials are underway. One — the PRELUDE Study — is designed to look into how clinics can provide PrEP in NSW. It will study whether people will […]

    Like